A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 55 Years of Age With Non-congenital Myotonic Dystrophy Type 1

Clinical trial NCT06844214 · RECRUITING

Trial details

NCT number: NCT06844214
Sponsor: Sanofi
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myotonic Dystrophy

Start date: 2025-07-23
Primary completion: 2029-02-28
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.